Search results
Super Common Health Conditions Can Make a Heat Wave More Dangerous: Here's How to Prepare
CNET· 5 days agoA heat wave is set to stifle parts of the US this week, with people across the Midwest and Northeast...
Phantom Cell Lines Undermine Cancer Research Credibility
Medscape· 4 days agoThis superficiality was illustrated by an image, created by artificial intelligence, of a mouse with...
How Neuroscience Is Leading the Next Wave of Skin-Care Innovation
PopSugar· 1 day agoNot to mention, aromatherapy uses scent to affect mood and CBD products bind to cannabinoid...
Johnson & Johnson (NYSE:JNJ) Shares Sold by Smith Shellnut Wilson LLC ADV
ETF DAILY NEWS· 6 days agoSmith Shellnut Wilson LLC ADV decreased its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 5.6% in the fourth quarter, according to its most recent Form 13F filing with ...
Hollings Renton Sells 1,950 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) Stock
ETF DAILY NEWS· 3 days agoAnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) Director Hollings Renton sold 1,950 shares of the business’s stock in a transaction dated Tuesday, June 18th. The stock was sold at an average ...
AbbVie (NYSE:ABBV) Shares Up 0%
ETF DAILY NEWS· 7 days agoShares of AbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 0% during mid-day trading on Thursday . The company traded as high as $166.45 and last traded at $166.15. ABBV has been the topic ...
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Zacks· 1 day agoFDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Imfinzi.
Here Comes the Sun: We Are Your Summer Skincare Experts
Lancaster Online· 2 days agoSummer is finally here and, for most of us, that means more time in the sun - whether it’s relaxing...
In a 'gold rush' for treating bowel disease, AbbVie clears one more stage
Crain s Chicago Business· 2 days agoWith the arrival of biosimilar competition for its blockbuster drug Humira, AbbVie has said much of its sales growth potential lies with these two anti-inflammatories. In April, the North Chicago ...
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 2 days agoThis approval is a significant milestone, making Skyrizi now available for four different conditions in the U.S., including psoriatic arthritis, plaque psoriasis, and Crohn ...